Table 1 Baseline characteristics and unadjusted associations with educational level

N (%)

771

Age, mean (SD)

70.7 (10.6)

Female, N (%)

317 (41.1)

 Intervention, N (%)

383 (49.7)

 Control, N (%)

388 (50.3)

 TIA, N (%)

301 (39.0)

 Stroke, N (%)^†

470 (61.0)

mRS score >2, N (%)

88 (11.4)

Current smoker, N (%)

106 (13.7)

BMI, mean (SD)^‡

27.0 (4.5)

AF, N (%)

129 (16.7)

IHD, N (%)

88 (11.4)

Previous stroke, N (%)^§

95 (12.3)

Diabetes, N (%)

128 (16.6)

CHF, N (%)

28 (3.6)

PAD, N (%)

22 (2.9)

Hypertension, N (%)

458 (59.4)

Antihypertensives, N (%)^{| |}

585 (76.2)

 1

215 (36.8)

 2

205 (35.0)

 ≥3

165 (28.2)

Lipid-lowering agent, N (%)^{| |}

605 (78.8)

 Simvastatin

487 (80.5)

 Atorvastatin

109 (18.0)

 Other

9 (1.5)

Antiplatelet drug, N (%)^{| |}

619 (80.6)

Warfarin, N (%)^{| |}

116 (15.1)